Production (Stage)
International Stem Cell Corporation
ISCO
$0.1542
$0.044240.18%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.45M | 2.18M | 2.33M | 2.13M | 1.89M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.45M | 2.18M | 2.33M | 2.13M | 1.89M |
| Cost of Revenue | 990.00K | 974.00K | 913.00K | 887.00K | 863.00K |
| Gross Profit | 1.46M | 1.21M | 1.42M | 1.24M | 1.03M |
| SG&A Expenses | 1.64M | 1.11M | 1.26M | 1.24M | 1.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.40M | 2.27M | 2.18M | 2.31M | 2.31M |
| Operating Income | 51.00K | -90.00K | 149.00K | -178.00K | -424.00K |
| Income Before Tax | 11.00K | -125.00K | 119.00K | -214.00K | -458.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.00K | -125.00K | 119.00K | -214.00K | -458.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.00K | -125.00K | 119.00K | -214.00K | -458.00K |
| EBIT | 51.00K | -90.00K | 149.00K | -178.00K | -424.00K |
| EBITDA | 105.00K | -37.00K | 199.00K | -129.00K | -376.00K |
| EPS Basic | 0.00 | -0.02 | 0.01 | -0.03 | -0.04 |
| Normalized Basic EPS | 0.00 | -0.01 | 0.01 | -0.02 | -0.04 |
| EPS Diluted | 0.00 | -0.02 | 0.01 | -0.03 | -0.04 |
| Normalized Diluted EPS | 0.00 | -0.01 | 0.01 | -0.02 | -0.04 |
| Average Basic Shares Outstanding | 8.00M | 8.00M | 8.00M | 8.00M | 8.00M |
| Average Diluted Shares Outstanding | 8.00M | 8.00M | 8.00M | 8.00M | 8.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |